C46H51N11O4 — CID 168770953
3-tert-butyl-N-[(1R)-1-[4-[6-[6-[4-[3-[4-[[(3S)-2,6-dioxopiperidin-3-yl]amino]phenyl]cyclobutyl]piperazin-1-yl]-3-pyridinyl]-7H-pyrrolo[2,3-d]pyrimidin-4-yl]-2-methylphenyl]ethyl]-1,2,4-oxadiazole-5-carboxamide (PubChem CID 168770953) has the molecular formula C46H51N11O4 and a molecular weight of 821.99 g/mol. Its IUPAC name is 3-tert-butyl-N-[(1R)-1-[4-[6-[6-[4-[3-[4-[[(3S)-2,6-dioxopiperidin-3-yl]amino]phenyl]cyclobutyl]piperazin-1-yl]-3-pyridinyl]-7H-pyrrolo[2,3-d]pyrimidin-4-yl]-2-methylphenyl]ethyl]-1,2,4-oxadiazole-5-carboxamide.
| Compound Name | 3-tert-butyl-N-[(1R)-1-[4-[6-[6-[4-[3-[4-[[(3S)-2,6-dioxopiperidin-3-yl]amino]phenyl]cyclobutyl]piperazin-1-yl]-3-pyridinyl]-7H-pyrrolo[2,3-d]pyrimidin-4-yl]-2-methylphenyl]ethyl]-1,2,4-oxadiazole-5-carboxamide |
|---|---|
| PubChem CID | 168770953 |
| Molecular Formula | C46H51N11O4 |
| Molecular Weight | 821.99 g/mol |
| Exact Mass | 821.41 |
| IUPAC Name | 3-tert-butyl-N-[(1R)-1-[4-[6-[6-[4-[3-[4-[[(3S)-2,6-dioxopiperidin-3-yl]amino]phenyl]cyclobutyl]piperazin-1-yl]-3-pyridinyl]-7H-pyrrolo[2,3-d]pyrimidin-4-yl]-2-methylphenyl]ethyl]-1,2,4-oxadiazole-5-carboxamide |
| SMILES | Cc1cc(-c2ncnc3[nH]c(-c4ccc(N5CCN(C6CC(c7ccc(N[C@H]8CCC(=O)NC8=O)cc7)C6)CC5)nc4)cc23)ccc1[C@@H](C)NC(=O)c1nc(C(C)(C)C)no1 |
| InChI | InChI=1S/C46H51N11O4/c1-26-20-29(8-12-34(26)27(2)50-43(60)44-54-45(55-61-44)46(3,4)5)40-35-23-37(52-41(35)49-25-48-40)30-9-14-38(47-24-30)57-18-16-56(17-19-57)33-21-31(22-33)28-6-10-32(11-7-28)51-36-13-15-39(58)53-42(36)59/h6-12,14,20,23-25,27,31,33,36,51H,13,15-19,21-22H2,1-5H3,(H,50,60)(H,48,49,52)(H,53,58,59)/t27-,31?,33?,36+/m1/s1 |
| InChIKey | MYAPVDMXAWGYLF-FCGNFQILSA-N |
| XLogP | 6.45 |
| TPSA | 187.16 Ų |
| H-Bond Donors | 4 |
| H-Bond Acceptors | 12 |
| Rotatable Bonds | 10 |
| Heavy Atoms | 61 |
| Complexity | — |
3 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 821.99 |
| LogP ≤ 5 | 6.45 |
| H-Bond Donors ≤ 5 | 4 |
| H-Bond Acceptors ≤ 10 | 12 |
| Structural Alerts | {'alert_name': 'phthalimide', 'substructure': 'N/A'} |
|---|